Chiropractic Rehabilitation for Relief From Migraines

Abstract

Migraine is a complex neurological disorder far beyond a simple headache. It involves abnormal processing in the brain and trigeminovascular system, with phases that can include prodrome, aura, headache, and postdrome. Symptoms range from throbbing unilateral pain, nausea, and extreme sensitivity to light, sound, and smell to fatigue, cognitive fog, and neck discomfort that disrupt work, family life, and daily function. Many people also experience ongoing interictal challenges such as concentration difficulties and anxiety between attacks. Evidence-based non-surgical approaches, including multimodal chiropractic care that addresses the upper cervical spine and trigeminocervical complex, physical therapy, massage, functional medicine strategies, lifestyle optimization, and—for qualifying patients with chronic migraine—onabotulinumtoxinA (Botox) administered according to established clinical guidelines, can form part of a comprehensive health and wellness routine. At Injury Medical Clinic PA (also known as Mission Plaza Injury Medical Clinic) in El Paso, Texas, Dr. Alexander Jimenez, DC, APRN, FNP-BC, CFMP, IFMCP, ATN, CCST, collaborates with Dr. Maria Guadalupe Cardenas, MD (Board Certified in Internal Medicine, NPI #1164426749, Texas MD License #J2933), who serves as Medical Director and Collaborative Physician. This multidisciplinary model integrates chiropractic care, medical oversight, functional medicine, rehabilitation, and personal injury care to support patients with migraines and related musculoskeletal factors. This educational post draws on current research and clinical observations to explain the physiology, daily impact, and practical integrative options.

What Migraine Is and How It Affects the Body

Migraine is a recurrent neurological condition characterized by attacks of moderate to severe head pain that typically last 4 to 72 hours if untreated. Research shows that migraine involves dysfunction in sensory processing, with a genetic predisposition interacting with environmental and behavioral factors. The underlying mechanisms center on the trigeminovascular system. Trigeminal sensory nerves innervate the meninges and cranial blood vessels. When activated, these nerves release neuropeptides such as calcitonin gene-related peptide (CGRP) and others, leading to neurogenic inflammation, vasodilation, and pain sensitization. Second-order neurons in the brainstem transmit signals to higher centers, including the thalamus and cortex, amplifying pain and associated symptoms.

The hypothalamus plays a key role in the cyclic nature of attacks and premonitory symptoms such as yawning, thirst, or mood changes. In some individuals, a wave of neuronal depolarization known as cortical spreading depression underlies aura symptoms. This electrical or chemical wave spreads across the cortex, producing visual, sensory, or language disturbances before or during the headache phase. Brainstem nuclei, including the periaqueductal gray and locus coeruleus, show altered activity, and the overall system exhibits lowered thresholds for sensory input, making ordinary stimuli feel overwhelming. Between attacks, residual changes in excitability and sensory processing can persist, contributing to ongoing vulnerability.

Comorbidities and systemic factors further influence the picture. Sleep disruption, hormonal fluctuations, inflammation, and neck strain can lower the migraine threshold by increasing afferent input into shared neural pathways. The result is not only head pain but a cascade that affects energy regulation, gastrointestinal function (nausea and vomiting), autonomic responses, and cognitive performance.

Phases and Various Symptoms of Migraine

Migraine attacks typically unfold in phases, though not every person experiences all of them, and phases can overlap.

• Prodrome (premonitory phase): Hours to days before pain, many people notice mood changes, irritability, fatigue, food cravings, frequent yawning, neck stiffness, increased urination, or difficulty concentrating. These reflect hypothalamic and brainstem activity.
• Aura: Occurs in roughly one-quarter of people. Visual symptoms are most common—flashing lights, zigzag lines, blind spots (scotomas), or shimmering spots. Sensory aura may involve tingling or numbness on one side of the face or body. Speech or language difficulties and, rarely, motor weakness may also occur. Aura usually lasts less than 60 minutes and relates to cortical spreading depression.
• Headache phase: Moderate to severe throbbing or pulsating pain, often unilateral but sometimes bilateral, frequently frontotemporal. It worsens with physical activity. Associated features include nausea (present in a large majority), vomiting, photophobia (light sensitivity), phonophobia (sound sensitivity), osmophobia (smell sensitivity), scalp tenderness, and neck pain. Cognitive fog and difficulty concentrating are common. The pain arises from sensitization in the trigeminovascular pathways and central processing changes.
• Postdrome: After the pain eases, many feel drained, confused, irritable, or “hungover” for up to 24–48 hours, with residual fatigue, mood shifts, or continued sensitivity.

Even between attacks, people may experience hypersensitivity, fatigue, concentration problems, sleep disturbance, or anxiety about the next episode. Symptoms vary widely; some attacks are milder and resemble tension-type headache, while severe ones are incapacitating. Neck pain and stiffness frequently accompany migraine, reflecting shared neural circuitry rather than a purely vascular process.

How Migraines Affect Day-to-Day Life and the Person

The burden extends well beyond the hours of pain. During an attack, most people need to withdraw to a dark, quiet room because light, sound, movement, or odors intensify symptoms. Work productivity drops dramatically through absenteeism and presenteeism (reduced function while present). Family responsibilities, social plans, and simple tasks such as driving, cooking, or caring for children become difficult or impossible. Cognitive symptoms—brain fog, slowed thinking, and memory lapses—impair decision-making and concentration even outside peak pain.

Over time, the unpredictability creates anticipatory anxiety and can contribute to depression or social isolation. Both attacks and recovery efforts often disrupt sleep. Physical activity is limited because it aggravates pain, potentially leading to deconditioning. In people with chronic migraine (15 or more headache days per month), the cumulative effect on quality of life, relationships, and economic participation is substantial. Research documents high rates of disability and comorbidity with anxiety, depression, and sleep disorders. The interictal period is not fully “normal”; residual sensory hypersensitivity and fatigue can leave a person feeling never fully recovered.

The Role of the Neck, Cervical Spine, and Trigeminocervical Complex

A critical anatomical fact is the trigeminocervical complex (TCC) in the upper cervical spinal cord and lower brainstem. Sensory fibers from the trigeminal nerve (which supplies the face, head, and meninges) converge with afferents from the upper cervical nerves (especially C1–C3) onto shared second-order neurons. This convergence explains why neck dysfunction can refer pain into the head and why many migraine patients report neck stiffness or pain. Irritation, restricted motion, or muscle tension in the upper cervical region can increase nociceptive traffic into the TCC, lowering the threshold for trigeminovascular activation and migraine attacks. Conversely, migraine sensitization can make cervical tissues more tender. Clinical observations and imaging studies support this bidirectional relationship. Addressing cervical biomechanics can therefore reduce one peripheral driver of central sensitization without claiming to “cure” the underlying neurological disorder.

Migraine Pain Treatment El Paso, TX Chiropractor- Video

Benefits of Chiropractic Care and Non-Surgical Treatments as Part of a Health and Wellness Routine

Integrative chiropractic care fits within a broader non-surgical framework that aims to reduce peripheral sensitization, improve biomechanics, support recovery, and raise the overall migraine threshold. Multimodal approaches typically include precise, low-force spinal adjustments or mobilizations focused on the upper cervical and thoracic spine, soft-tissue and myofascial release techniques, postural rehabilitation, and patient education. The rationale is to normalize mechanoreceptor input from the neck, decrease aberrant signaling into the TCC, deactivate trigger points that contribute to local and referred pain, and restore better movement patterns so daily strain does not continually feed the system.

Evidence for spinal manipulation alone in migraine is mixed and often rated low or very low certainty due to methodological limitations, small samples, and heterogeneity. Some trials and pilot studies of multimodal chiropractic care (manipulation plus soft-tissue work, exercise, and education) have shown fewer migraine days than usual care alone. Systematic reviews note potential modest benefits for frequency or intensity in certain patients while emphasizing the need for larger, rigorous trials. Massage therapy, physical therapy focusing on cervical mobility and deep neck flexor strengthening, aerobic exercise, and relaxation training have supportive data of varying strength and can be combined safely in most people. Functional wellness strategies address sleep, nutrition, hydration, stress physiology, and potential inflammatory or metabolic contributors that interact with the neurological substrate.

In clinical practice, clinicians select these modalities because they target modifiable mechanical and physiological inputs that interact with core migraine mechanisms. They are not substitutes for appropriate medical evaluation or proven pharmacologic preventives when indicated; they are complementary tools that many patients find helpful for reducing attack burden and improving function when integrated thoughtfully. At the clinic, careful assessment distinguishes migraine from cervicogenic headache or medication-overuse patterns and coordinates care accordingly.

How Botox Helps with Migraines and Clinical Guidelines for Use

OnabotulinumtoxinA (Botox) is FDA-approved for the prevention of headaches in adults with chronic migraine—defined as headaches on 15 or more days per month, with migraine features on at least 8 of those days, lasting 4 hours or longer. It is not approved for episodic migraine (fewer than 15 headache days). The American Migraine Foundation and product labeling emphasize this distinction: higher baseline frequency is associated with better response.

Mechanism: Tiny doses are injected into specific head and neck muscles. The toxin enters nerve endings and inhibits the release of neurotransmitters involved in pain signaling, including effects on CGRP-related pathways and peripheral sensitization. It does not primarily work by relaxing muscles cosmetically; the goal is to interrupt the peripheral drive into central pain networks before attacks fully develop. Effects build over successive treatment cycles; one cycle lasts approximately 10–12 weeks, and maximum benefit may require two or three cycles (up to about six months). PREEMPT trial data showed an average reduction of roughly 8.4 headache days versus 6.6 with placebo at 24 weeks, with improvements in disability and quality-of-life measures. Recent AAN/AHS systematic reviews support high-confidence evidence that it reduces headache frequency in chronic migraine.

Protocol: 155 units administered intramuscularly at 31 sites across seven muscle regions (frontalis, corrugator, procerus, occipitalis, temporalis, trapezius, and cervical paraspinals) every 12 weeks. The procedure takes about 20 minutes with a small needle. Common side effects include neck soreness (manageable with ice), injection-site discomfort, and, less often, eyelid droop or muscle weakness. Serious distant spread is rare at labeled doses. Insurance typically requires prior failure of at least two other preventive medications. Patients continue other acute or preventive medications as appropriate; standard migraine therapies have no major drug-interaction concerns. Assess efficacy after at least 24 weeks at the full dose. Botox is one evidence-based option among several (including CGRP-targeted therapies) and is best delivered by experienced clinicians after accurate diagnosis and shared decision-making.

Home Strategies People Can Use to Reduce Migraines

Lifestyle consistency is foundational because irregular sleep, meals, hydration, and stress lower the migraine threshold.

• Maintain regular sleep and wake times, even on weekends; aim for adequate duration and quality in a dark, cool room.
• Eat regular meals and stay well hydrated; keep a diary to identify personal food or caffeine triggers while avoiding extreme restriction.
• Incorporate regular moderate aerobic exercise and gentle neck mobility or postural exercises once a clinician clears you; avoid intense activity during an attack.
• Practice stress-reduction techniques such as diaphragmatic breathing, progressive relaxation, or mindfulness; these can modulate autonomic and pain-processing pathways.
• During early symptoms or an attack, rest in a dark, quiet space; apply cold or warm compresses to the head or neck as preferred; small amounts of caffeine may help some people if used judiciously.
• Track attacks, triggers, medications, and response in a diary to guide treatment decisions with the care team.

These steps support the same physiological goals as clinic-based care: raising the sensory threshold and reducing cumulative load on the nervous system. They are most effective when combined with medical and integrative strategies rather than used in isolation.

Integrative Team Approach at Injury Medical Clinic PA

Dr. Alexander Jimenez, DC, APRN, FNP-BC, CFMP, IFMCP, ATN, CCST, provides chiropractic evaluation and treatment focused on musculoskeletal contributors, functional medicine assessment, and coordination of non-surgical rehabilitation. Dr. Maria Guadalupe Cardenas, MD, Board-Certified in Internal Medicine and with more than 40 years of experience as an internist, serves as Medical Director and Collaborative Physician. She supplies medical oversight, evaluates comorbidities, manages complex medical issues, and ensures that any pharmacologic or injection-based options (including referral pathways for Botox when appropriate) meet standards of safety and appropriateness. This multidisciplinary model is common in integrative and personal-injury clinics: the chiropractor addresses biomechanical and functional drivers while the internist provides diagnostic and medical direction. Together, the team evaluates the full picture—neurological symptoms, cervical findings, sleep, nutrition, medications, and lifestyle—and builds individualized plans that may include chiropractic adjustments, soft-tissue work, physical therapy, functional strategies, and coordination with neurology when Botox or other preventives are indicated. The goal is shared decision-making that respects patient preferences, maximizes benefit, and minimizes unnecessary risk.

Conclusion

Migraine is a multifaceted neurological disorder involving the trigeminovascular system, CGRP signaling, brainstem and hypothalamic modulation, and interactions with cervical afferents via the trigeminocervical complex. Attacks and interictal symptoms substantially impair daily life. Integrative non-surgical care—multimodal chiropractic approaches that reduce peripheral sensitization from the neck, physical therapy, massage, functional wellness, lifestyle optimization, and, for appropriate chronic migraine patients, guideline-directed Botox—can be incorporated into a comprehensive routine in collaboration with their medical team. At Injury Medical Clinic PA in El Paso, the partnership between Dr. Jimenez and Dr. Cardenas exemplifies this coordinated model. Patients benefit most from accurate diagnosis, consistent self-management, and a personalized combination of evidence-informed strategies.

References

• American Migraine Foundation. (n.d.). Botox for migraine.
• Mayo Clinic. (2025). Migraine.
• National Institute of Neurological Disorders and Stroke. (2026). Migraine.
• Dr. Alexander Jimenez. Clinical observations and educational materials. dralexjimenez.com and LinkedIn.
• Additional supporting literature on pathophysiology, multimodal care, and guidelines as cited inline from peer-reviewed sources and clinical reviews.

SEO tags

migraine symptoms, chronic migraine treatment, chiropractic care for migraines, Botox for migraines, integrative migraine care, trigeminocervical complex, non-surgical migraine management, El Paso migraine clinic, Dr. Alexander Jimenez, functional medicine migraines, cervical spine migraine, lifestyle migraine prevention, Injury Medical Clinic PA, multimodal headache treatment, CGRP migraine physiology